<DOC>
	<DOCNO>NCT00672529</DOCNO>
	<brief_summary>The purpose study 1 . To pilot research methodology randomize trial orthomolecular treatment regime versus placebo add-on therapy child asthma ; 2 . To obtain preliminary estimate effectiveness orthomolecular treatment regime allow taper inhaled corticosteroid clinically stable asthmatic child . The obtained estimate allow sample size calculation full-scale randomized trial ; 3 . To obtain preliminary information safety tolerability orthomolecular treatment regime .</brief_summary>
	<brief_title>Orthomolecular Therapy Asthma Children</brief_title>
	<detailed_description>An orthomolecular treatment approach combine supplement , date , test , although commonly use naturopathic practitioner treat respiratory problem individual child . A well-designed controlled trial need determine approach effective . This small study establish guideline large trial follow . This propose research particularly important , trend use natural treatment may encourage non-compliance conventional medical treatment , lead poor asthma control .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Male female age 7 18 year Mild moderate asthma diagnose respirologist Use budesonide dose 200800 µg/d ( equivalent corticosteroid therapy ) ≥3 month Stable asthma , define significant change regular asthma medication acute asthma exacerbation require corticosteroid rescue least 3 month enrollment runin phase . Asthma symptom must good control Baseline force expiratory volume 1 second ( FEV1 ) &gt; = 70 % predict normal value . Possible participant treat orthomolecular therapy within previous year require wash period 7 day prior enrolment trial . ( Vitamin C &gt; 200mg , Vitamin E &gt; 50IU , Vitamin B12 &gt; 100µg , Magnesium &gt; 200mg , Selenium &gt; 50µg , Omega3 &gt; 300mg , Quercetin &gt; 3mg , Vitamin B6 &gt; 75mg consider orthomolecular dos ) . Known hypersensitivity component orthomolecular therapy placebo . Acute infectious sinusitis respiratory tract infection active lung disease allergic asthma within 1 month significant systemic disease within 3 month study entry visit .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Childhood Asthma</keyword>
	<keyword>Inhaled Corticosteroids</keyword>
	<keyword>Alternative Medicine</keyword>
	<keyword>Vitamins , mineral , fish oil Add-on Treatment</keyword>
</DOC>